These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12938633)

  • 1. [Dendritic cells and their role in inflammation in the central nervous system].
    Pashchenkov MV; Pinegin BV; Link Kh; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; (Spec No 2):39-46. PubMed ID: 12938633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cells and microglia as drivers of multiple sclerosis pathology.
    Friese MA; Fugger L
    Brain; 2007 Nov; 130(Pt 11):2755-7. PubMed ID: 17956912
    [No Abstract]   [Full Text] [Related]  

  • 3. Control of autoimmune CNS inflammation by astrocytes.
    Rothhammer V; Quintana FJ
    Semin Immunopathol; 2015 Nov; 37(6):625-38. PubMed ID: 26223505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response.
    Lowther DE; Chong DL; Ascough S; Ettorre A; Ingram RJ; Boyton RJ; Altmann DM
    Acta Neuropathol; 2013 Oct; 126(4):501-15. PubMed ID: 23934116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of multiple sclerosis.
    Ffrench-Constant C
    Lancet; 1994 Jan; 343(8892):271-5. PubMed ID: 7905102
    [No Abstract]   [Full Text] [Related]  

  • 6. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of lectin-glycan recognition systems and immune cell networks in CNS inflammation.
    Mendez-Huergo SP; Maller SM; Farez MF; Mariño K; Correale J; Rabinovich GA
    Cytokine Growth Factor Rev; 2014 Jun; 25(3):247-55. PubMed ID: 24684768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell trafficking in the central nervous system.
    Sallusto F; Impellizzieri D; Basso C; Laroni A; Uccelli A; Lanzavecchia A; Engelhardt B
    Immunol Rev; 2012 Jul; 248(1):216-27. PubMed ID: 22725964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cells in multiple sclerosis.
    Severson C; Hafler DA
    Results Probl Cell Differ; 2010; 51():75-98. PubMed ID: 19582415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the immunopathogenesis of multiple sclerosis.
    Yadav SK; Mindur JE; Ito K; Dhib-Jalbut S
    Curr Opin Neurol; 2015 Jun; 28(3):206-19. PubMed ID: 25887768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term evolution of autoreactive T cell repertoire in multiple sclerosis.
    Vergelli M; Mazzanti B; Traggiai E; Biagioli T; Ballerini C; Parigi A; Konse A; Pellicanò G; Massacesi L
    J Neurosci Res; 2001 Nov; 66(3):517-24. PubMed ID: 11746371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system.
    Larochelle C; Cayrol R; Kebir H; Alvarez JI; Lécuyer MA; Ifergan I; Viel É; Bourbonnière L; Beauseigle D; Terouz S; Hachehouche L; Gendron S; Poirier J; Jobin C; Duquette P; Flanagan K; Yednock T; Arbour N; Prat A
    Brain; 2012 Oct; 135(Pt 10):2906-24. PubMed ID: 22975388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis: a complicated picture of autoimmunity.
    McFarland HF; Martin R
    Nat Immunol; 2007 Sep; 8(9):913-9. PubMed ID: 17712344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is damage in central nervous system due to inflammation?
    Chavarria A; Alcocer-Varela J
    Autoimmun Rev; 2004 Jun; 3(4):251-60. PubMed ID: 15246020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
    Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
    J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and cellular localization of major histocompatibility complex antigens in active multiple sclerosis lesions.
    Hayashi T; Burks JS; Hauser SL
    Ann N Y Acad Sci; 1988; 540():301-5. PubMed ID: 3061338
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunology of Multiple Sclerosis.
    Sospedra M; Martin R
    Semin Neurol; 2016 Apr; 36(2):115-27. PubMed ID: 27116718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The possible role of prolactin in the immunopathogenesis of multiple sclerosis.
    Draca S; Lević Z
    Med Hypotheses; 1996 Aug; 47(2):89-92. PubMed ID: 8869921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deleterious versus protective autoimmunity in multiple sclerosis.
    Kostic M; Stojanovic I; Marjanovic G; Zivkovic N; Cvetanovic A
    Cell Immunol; 2015 Aug; 296(2):122-32. PubMed ID: 25944389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
    Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
    Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.